A Survey of Management of Analgesia, Sedation and Delirium in ICU Patients in China

NCT04217915 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2021-07-13

No results posted yet for this study

Summary

In 2018, the severe medicine branch of the Chinese Medical Association and the American Society of severe medicine successively updated the pain and sedation guidelines for severe patients (PADIS guidelines). In addition to the update of the original evaluation and management of pain and sedation and delirium, the new guidelines also increased the monitoring and management of early activities and sleep quality for severe patients. Therefore, it is necessary for us to investigate the compliance of the new guidelines for analgesia, sedation and delirium management among the medical staff of critical care, so as to find out the existing problems in the management of analgesia, sedation and delirium in critical care patients, and find solutions to improve the overall quality level of our management of critical care patients

Conditions

  • Delirium on Emergence
  • Analgesia
  • Separation

Sponsors & Collaborators

  • The Second Affiliated Hospital of Kunming Medical University

    collaborator OTHER
  • First Affiliated Hospital of Kunming Medical University

    collaborator OTHER
  • First Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • The First Affiliated Hospital of Dalian Medical University

    collaborator OTHER
  • Peking University People's Hospital

    collaborator OTHER
  • Qilu Hospital of Shandong University

    collaborator OTHER
  • The Second Affiliated Hospital of Dalian Medical University

    collaborator OTHER
  • The Second Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • The First Hospital of Jilin University

    collaborator OTHER
  • General Hospital of Ningxia Medical University

    collaborator OTHER
  • China Medical University, China

    lead OTHER

Principal Investigators

  • xiaochun ma, doctor · China Medical University, China

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-12
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04217915 on ClinicalTrials.gov